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cooperate to induce persistence
Rick A. Fasani and Michael A. Savageau
Department of Biomedical Engineering and Microbiology Graduate Group, University of California, Davis,
One Shields Avenue, Davis, CA 95616, USA
Persisters are drug-tolerant bacteria that account for the majority of bacterial
infections. They are not mutants, rather, they are slow-growing cells in an
otherwise normally growing population. It is known that the frequency of
persisters in a population is correlatedwith the number of toxin–antitoxin sys-
tems in the organism.Our previouswork provided amechanistic link between
the two by showing howmultiple toxin–antitoxin systems, which are present
in nearly all bacteria, can cooperate to induce bistable toxin concentrations that
result in a heterogeneous population of slow- and fast-growing cells. As such,
the slow-growing persisters are a bet-hedging subpopulation maintained
under normal conditions. For technical reasons, the model assumed that the
kinetic parameters of the various toxin–antitoxin systems in the cell are iden-
tical, but experimental data indicate that they differ, sometimes dramatically.
Thus, a critical question remains: whether toxin–antitoxin systems from the
diverse families, often found together in a cell, with significantly different
kinetics, can cooperate in a similar manner. Here, we characterize the inter-
action of toxin–antitoxin systems from many families that are unrelated
and kinetically diverse, and identify the essential determinant for their
cooperation. The generic architecture of toxin–antitoxin systems provides the
potential for bistability, and our results show that evenwhen theydonot exhibit
bistability alone, unrelated systems can be coupled by the growth rate to create a
strongly bistable, hysteretic switch between normal (fast-growing) and persist-
ent (slow-growing) states. Different combinations of kinetic parameters can
produce similar toxic switching thresholds, and the proximity of the thresholds
is the primary determinant of bistability. Stochastic fluctuations can spon-
taneously switch all of the toxin–antitoxin systems in a cell at once. The
spontaneous switch creates a heterogeneous population of growing and non-
growing cells, typical of persisters, that exist under normal conditions, rather
than only as an induced response. The frequency of persisters in the population
can be tuned for a particular environmental niche by mixing and matching
unrelated systems via mutation, horizontal gene transfer and selection.1. Introduction
Persisters have traditionally been identified as subpopulations of cells that survive
antibiotic treatment via epigeneticmeans. Theywere first recognizedwhile treating
Staphylococcuswithpenicillin [1] andwere later identified as the sourceofmultidrug
tolerance in biofilms [2], making them responsible for 65% to 80% of bacterial infec-
tions [3,4]. Persisters have been implicated in the stubborn Pseudomonas aeruginosa
infections to which most cystic fibrosis patients eventually succumb [5], as well as
the oral Candida albicans infections common in cancer patients [6]. They may
also explain the recurrence of Mycobacterium tuberculosis infections, responsible
for 1.6 million deaths each year [7].
Persistence is not the result of a geneticmutation, but rather of a heterogeneous
population. Modern single-cell studies have confirmed that persisters are rare,
slowly growing cells [8], and that slowly growing cells are less susceptible to anti-
biotics [9]. More recent evidence suggests that slow growth is not necessary for nor
a guarantee of persistence, but still increases the likelihood [10]. The mechanisms
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2that provide the antibiotic tolerance are not fully understood,
but one common path to persistence appears to be through
the pervasive and varied toxin–antitoxin systems [11]. Toxin–
antitoxin systems are genetic modules, commonly found in
free-living bacteria, that generally consist of two co-produced
and co-regulated components: a relatively stable toxin that inhi-
bits cell growth and a more labile antitoxin that specifically
neutralizes the toxin. Stress can upregulate the proteases that
degrade the antitoxin, thereby freeing the toxin [12]. The over-
expression of toxin can slow growth [13–19] and confer
multidrug tolerance [18,20–22]. Conversely, multiple toxin–
antitoxin systems are upregulated in persister-enriched samples
[21,23]. In fact, the first gene tied to persistence was hipA [24],
later identified as the toxic half of a toxin–antitoxin pair.
Toxin–antitoxin systemsare foundon the chromosomes and
plasmids of most bacterial species and strains—the Escherichia
coli K-12 genome boasts at least 36 [25] and the M. tuberculosis
genome contains 88, more than any other human pathogen
[26]. Yet, despite a growing understanding of the mechanisms
underlying toxin–antitoxin systems, several important ques-
tions remain unanswered. What are their functions and how
does each contribute to different cellular phenotypes or fates
[27]? Why are there multiple types and apparently redundant
systems in a single cell [28]? What is their coordinating signal
[29]? Our previous work [30] answered some of these questions
by forming a general model of the common type II toxin–
antitoxin systems that target protein synthesis, and comparing
the model behaviour to existing experimental results. Previous
treatments addressed various aspects of toxin–antitoxin
systems or persistent populations [8,31–36], whereas our
analysis was the first to encompass them all, includingmolecu-
lar mechanisms of regulation, stochastic fluctuations, variable
growth, and population dynamics, and to do so over a broad
range of parameter values. We were able to describe a connec-
tion between the molecular mechanisms of toxin–antitoxin
systems, the cooperation among systems to produce bistable
expression, and the slow growth that is commonly associated
with the persistent phenotype.
Our previous results [30] confirmed and explained genetic
experiments [29] that revealed a characteristic and important
relationship between the number of toxin–antitoxin genetic cas-
settes and the frequency of persisters that survive antibiotic
treatment. Furthermore, these results suggested that although
the specifics may vary, toxin–antitoxin systems are potentially
bistable and can create a hysteretic switch between normal
and persistent states. A bistable system can exhibit one of two
stable behaviours under the same conditions, and it has
become apparent that bistable genetic regulatory networks,
when operating in noisy, fluctuating environments, can lead to
heterogenous populations of cells. This can be seen in Bacillus
subtilis genetic competence, spore formation, and swimming
or chaining, as well as the persistent phenotype studied here
[37]. We previously showed [29] how toxin–antitoxin systems
that do not exhibit bistability alone can be coupled to produce
the same effect. Moreover, the total number of toxin–antitoxin
systems in a cell tunes the frequency of persisters, using the
growth rate as the coordinating signal.
For tractability in treating the large numbers of toxin–
antitoxin systems, our previous analysis considered the
systems kinetically identical, even if their specific mechan-
isms differed. Indeed, the fact that the toxins inhibit protein
production via diverse molecular methods and targets creates
a multihit mechanism that is necessary for cooperativity, butnot always sufficient—it can be readily shown that two sys-
tems with randomly chosen, differing kinetics do not always
cooperate. Therefore, critical questions remain: whether or
not toxin–antitoxin systems from different families—with
similar motifs but dramatically different kinetics—cooperate,
and if so, what the essential factors are that determine
their cooperation.
Here, we remove the key restriction that provided tractabil-
ity in the original model and account for multiple distinct
toxin–antitoxin systems. We mix and match systems with kin-
etic parameters that varyover an order ofmagnitude, reflecting
the parameter ranges that have been measured across several
well-studied toxin–antitoxin families. The results extend our
past findings, as well as offer new insight. In particular,
multiple unrelated toxin–antitoxin systems cooperate via the
growth rate, particularly in the presence of stochastic fluctu-
ations, to robustly increase the size of the bistable region and
the frequency of persisters. Furthermore, the size of the bistable
region not only depends on the parameters of each system, but
critically on their relative switching thresholds—the value of
the stimulus at the inflection point of the toxin induction
characteristic. As such, different toxin–antitoxin systems
can be mixed and matched to provide the variation on which
selection can act to tune the persister frequency for a given
environmental niche.2. Methods
2.1. Single-system model
Toxin–antitoxin systems use different protein structures and
mechanisms, yet are consistent in overall architecture. Here, we
describe a generic model for a large class of toxin–antitoxin
systems: type II systems that target protein synthesis. Figure 1a
depicts the common species and their interactions, and figure 1b
represents a generic model for toxin–antitoxin systems, where A
and T are the concentrations of free antitoxin and toxin, respect-
ively. T can represent either monomeric or dimeric toxin,
provided the toxin completely folds anddimerizes at physiological
concentrations. We assume that the synthesis and degradation
of the polycistronic message,M, as well as the formation and dis-
sociation of the toxin–antitoxin complexes, C andD, are relatively
fast comparedwith the rest of the system. As such, the dynamics of
a single toxin–antitoxin system can be described by the following
system of conventional differential equations:
dA
dt
¼ b 1
1þ Tn=KnT
samax
1þ (A2=K2P1)þ (2A2T=K2P2KH)p þ A2T2=K2P1K2H
 b mmax
1þ Tn=KnT
A lAAþ jA
(2:1)
and
dT
dt
¼ b 1
1þ Tn=KnT
amax
1þ (A2=K2P1)þ (2A2T=K2P2KH)p þ A2T2=K2P1K2H
 b mmax
1þ Tn=KnT
T  lTT þ jT ,
(2:2)
or by differential algebraic equations in the generalized mass
action form [38]:
dA
dt
¼ samaxbX1Y1  mmaxbX1A lAAþ jA, (2:3)
dT
dt
¼ amaxbX1Y1  mmaxbX1T  lTT þ jT , (2:4)
M1
A1
T1
C1
D1
toxinantitoxin
(a)
(b)
M2
A2
T2
C2
D2
toxin antitoxin
Figure 1. Model of coupled toxin–antitoxin systems. (a) The toxin and antitoxin are translationally coupled. The antitoxin binds and neutralizes the toxin, and can
optionally bind a second toxin. The antitoxin dimer, either alone or in complex, autorepresses transcription by binding to one or more operators in the promoter
region. The toxin enhances repression, in some cases via a bridging mechanism. Free antitoxin is relatively labile and degraded by various proteases (not shown).
Free toxin usually inhibits some aspect of global translation. (b) M, mRNA; A, antitoxin; T, toxin; C, antitoxin bound to one toxin; D, antitoxin bound to two toxins.
A and T are both translated from the polycistronic message M. Antitoxin alone or in complex—A, C or D—autorepresses transcription. Free toxin T inhibits trans-
lation, including its own. All species are degraded, and diluted by cellular growth. The degradation of A increases with proteolytic activity (not shown), and dilution
is slowed when T inhibits global translation and growth (not shown). Either toxin—T1 or T2—can inhibit translation in both systems as well as the overall growth
rate, which slows the dilution of all species.
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3X ¼ 1þ T
n
KnT
(2:5)
and Y ¼ 1þ A
2
K2P1
þ 2A
2T
K2P2KH
 p
þ A
2T2
K2P1K
2
H
: (2:6)
Equations (2.3)–(2.6) comprise a simplified model that retains the
essential features of the version used in our previous work [30].
In both equations (2.3) and (2.4), the first and only positive term
on the right-hand side represents protein synthesis. Themultiplica-
tive factor s represents the translational coupling between toxin
and antitoxin, and amax is the maximum rate of protein synthesis.
The second term represents protein loss due to dilution, where
mmax is the maximum growth rate constant. The third term in
each equation represents protein loss due to active degradation,
where lA is the degradation rate constant of antitoxin and lT is
the degradation rate constant of toxin. Both protein synthesis
and cellular growth are slowed by the toxic inhibition of trans-
lation X21 [14,17], which is defined by equation (2.5). The impact
of the free toxin X21 follows a Hill equation with Hill number n
and a concentration for half-maximal activity KT. Similarly, the
independent, unitless parameter b reflects an external change
that simultaneously lowers protein synthesis and cellular
growth, or amax and mmax. Protein synthesis is also proportionalto the fraction of unbound promoter, Y21, defined by equation
(2.6). In most well-studied toxin–antitoxin systems, the operators
are dissimilar, with one dominant, high-affinity site [39–44]. In
this model, we ignore the weaker sites or, for the cooperatively
binding complex, treat the sites in aggregate. The second term
represents the dimerization of the antitoxin on the surface of the
promoter, with a concentration of half-maximal binding at KP1.
The third term represents the cooperative binding of the complex
C to the promoter, with Hill number p and a dissociation constant
KP2 that represents increased affinity. The complexC formswhen a
toxin binds the antitoxin dimer at one of two independent sites
with a dissociation constant KH. The single toxin can bind to
either site, and hence binds with twice the affinity, or 2/KH.
The fourth term assumes that the complex D binds the operator
with the same affinity as the bare dimer, or KP1. The complex D
forms when two toxins bind the antitoxin dimer with overall
affinity 1=K2H :
Studies over the past decade have confirmed the importance
of stochastic fluctuations, or noise, in gene expression and gen-
etic networks [45]. Noise is added to the model by augmenting
equations (2.3) and (2.4) with additive noise terms, producing
stochastic differential equations in Langevin form. ji is a white
noise term with zero mean, kji(t)l ¼ 0, and d-autocorrelation,
kji(t)ji(s)l ¼ dd(t 2 s), where d is proportional the strength of
Table 1. Parameter estimates and alternative designs. Values listed under S1 were originally estimated in our previous work [30], based on the published
literature for six well-studied toxin–antitoxin systems. Alternative designs S2–S7 include multiple twofold, fourfold or 10-fold changes—marked in bold—to
the estimated parameters. The toxin and antitoxin half-lives, tT and tA, as well as the maximum cellular doubling time, tm, are shown here rather than their
corresponding rate constants, which are trivially related by lT ¼ ln 2/tT, lA ¼ ln 2/tA and mmax ¼ ln 2/tm. In every design, p ¼ 2, n ¼ 2 and tm ¼ 30 min.
parameter S1 S2 S3 S4 S5 S6 S7
tA (min) 60 120 240 60 120 240 120
tT (h) 48 96 192 48 96 192 96
s 10 10 2.5 2.5 10 10 10
amax (nM min
21) 1 1 1 4 1 0.25 1
KH (nM) 100 100 100 400 100 25 100
KP1 (mM) 1 1 1 1 10 1 0.1
KP2 (nM) 10 10 2.5 10 10 2.5 10
KT (nM) 10 10 10 40 10 2.5 10
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4the perturbation. Together, equations (2.3)–(2.6) form a tractable,
generic model of toxin–antitoxin regulation.2.2. Coupled-systems model
Experimental evidence indicates that one toxin–antitoxin system can
trigger another, unrelated toxin–antitoxin system [46–48]. Our
previous work suggested an indirect method of accomplishing
such coupling [30]. If one system alone increases its own toxin
concentration in response to a specific stress, and consequently
slows protein production and growth, then another identical
systemmay respond to the change ingrowth just as itwould respond
to a decrease in b. In this work, we extended the model to include
a second, unrelated toxin–antitoxin system, as illustrated in figure
1. The extended model is described by equations (2.7)–(2.13), in
which equations (2.7)–(2.9) describe the first system and
equations (2.10)–(2.12) describe the second. Both subsets of
equations mirror equations (2.3), (2.4) and (2.6) of the single-
system model. The maximum growth rate constant mmax and
the parameter b are the same for both systems, whereas the
other parameters can take on separate values. The systems are
coupled by equation (2.13), where either toxin can affect both
systems by attenuating global protein production and growth.
dA1
dt
¼ s1amax,1bX1Y11  mmaxbX1A1  lA,1A1 þ jA,1, (2:7)
dT1
dt
¼ amax,1bX1Y11  mmaxbX1T1  lT,1T1 þ jT,1, (2:8)
Y1 ¼ 1þ A
2
1
K2P1,1
þ 2A
2
1T1
K2P2,1KH,1
 ! p,1
þ A
2
1T
2
1
K2P1,1K
2
H,1
, (2:9)
dA2
dt
¼ s2amax,2bX1Y12  mmaxbX1A2  lA,2A2 þ jA,2, (2:10)
dT2
dt
¼ amax,2bX1Y12  mmaxbX1T2  lT,2T2 þ jT,2, (2:11)
Y2 ¼ 1þ A
2
2
K2P1,2
þ 2A
2
2T2
K2P2,2KH,2
 !p,2
þ A
2
2T
2
2
K2P1,2K
2
H,2
(2:12)
and X ¼ 1þ T
n,1
1
Kn,1T,1
Tn,22
Kn,2T,2
: (2:13)
The known toxins target their own unique steps in translation [49]
and it can be shown that their combined impact on translation is
often multiplicative. For example, RatA blocks the association
of the ribosomal subunits [50], whereas MazF cleaves mRNA
[51]—decreasing both the concentration of functional ribosomes
by half and the concentration of mRNA by half would reduce trans-
lation initiation fourfold. The coupled model nearly doubles thenumber of variables and parameters, but the same computational
methods can be applied.
2.3. Parameter values
Apart from noise, the single-systemmodel contains 11 parameters,
whichwe estimated in previouswork, based on the published data
for six of the best-studied toxin–antitoxin systems: kis-kid ( pemIK),
ccdAB, mazEF, phd-doc, relBE and yefM-yoeB [30]. Table 1 includes
the previously estimated parameter values. For technical reasons,
in our previous work, we treated the kinetics of all toxin–antitoxin
systems as identical. However, the published data indicate that
toxin–antitoxin kinetics vary between families, sometimes over
multiple orders of magnitude. Here, in addition to the original
parameter estimates, we consider alternative sets of parameters,
or alternative designs, that include various fold changes to the esti-
mated values. The additional parameters are listed in table 1. The
alternative sets of parameters vary over a broad range, but are not
random. They were deliberately chosen for reasons we will make
clear later in the text.
2.4. Computational procedures
We constructed and analysed the system design space using the
Design Space Toolbox for Matlab v. 1.0 [52]. We simulated the
deterministic model with the Matlab stiff solver, ode15 s.
We simulated the stochastic model with our own implementation
of the Euler–Maruyama method [53] in Matlab. All tests were
performed using Matlab v. 7.8 (R2009a).3. Results
3.1. Coupled cooperativity
The interaction of unrelated systems can bemodelled by setting
the parameters of equations (2.7)–(2.13) to represent two sys-
tems with different kinetics. Figure 2 shows the interaction of
nearly identical systems where the difference in a single par-
ameter value creates varying degrees of separation in their
switching thresholds, or the value of the stimulus at the inflec-
tion point of the toxin induction characteristic. Figure 2a
depicts the toxin profile of the first system, with the originally
estimated parameter values, in response to changing lA, which
is commonly correlated with changing proteolysis and
stress. Note that the system does not exhibit hysteretic bista-
bility, whereas a nearly identical system in our previous
work did. In our previous model, the toxin concentrations for
0.6
0.8
1.0
1.2
1.4
1.6
1.8
0 2–2–4–6–8 4 6 8
0.6
0.8
1.0
1.2
1.4
1.6
1.8
lo
g 1
0 
T 2
 
(nM
)
lo
g 1
0 
T 1
 
(nM
)
(a) (c)
(b) (d)
log2 lA,i/lA,i0 log2 lA,i/lA,i0
0 2–2–4–6–8 4 6 8
Figure 2. Toxin induction profiles for coupled and uncoupled systems. Steady-state toxin concentrations, T1 and T2, as a function of the changing rate constant for
antitoxin degradation in both systems lA,i. An increase in lA,i is commonly associated with an increase in stress. Changes in lA,i are measured as a fold change from
the normal values l0A,i: The proteolytic activity changes lA,i in both systems simultaneously, i.e. lA,1=l
0
A,1 ¼ lA,2=l0A,2: (a) Uncoupled reference system, using the
originally estimated parameter values (dashed black). (b) Uncoupled additional systems using the same parameter values, except varying the normal rates of
antitoxin degradation: l0A,2 ¼ 64l0A,1 (blue), 8l0A,1 (light blue), l0A,1 (green), 1=8l0A,1 ( pink) and 1=64l0A,1 (red). The toxic thresholds, or the values of the stimulus
at the inflection points of the toxin induction characteristics, are evenly spaced at approximately –3.7 (blue), –0.7 (light blue), 2.3 (green) and 5.3 (pink).
(c,d ) Steady-state toxin concentrations (dashed colour) when the reference system (a, dashed black) is coupled with each of the additional systems (b, solid
colour). (c) The coupled reference system and (d ) the coupled additional systems when l0A,2 ¼ 64l0A,1 (dashed blue), 8l0A,1 (dashed light blue), l0A,1 (dashed
green), 1=8l0A,1 (dashed pink) and 1=64l
0
A,1 (dashed red).
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5half-maximal impact on growth (KT1) and protein produc-
tion (KT2) were allowed to differ; here the toxin has the same
impact (KT) on both, as defined by equation (2.5). This
change eliminates the hysteretic region evident in our previous
work and allows us to show here how systems that do not exhi-
bit hysteresis individually can still cooperate via changes in
growth rate to create hysteresis. Figure 2b shows the toxin pro-
files when a second, uncoupled system has the same, or nearly
the same, parameter values, differing only in the normal rate
constant for antitoxin degradation l0A,2: When the antitoxin is
more stable (e.g. figure 2b, red), the proteolytic activity must
increase further to reach the toxic threshold. Again, there is
no bistability. Figure 2c,d illustrates the effect of coupling the
first and second systems and increasing their rate constants
for antitoxin degradation proportionally, as would be the case
when both systems respond to the same protease. When the
toxic thresholds are far apart, the system with the lowest
threshold switches as it would in isolation (e.g. figure 2d,
dotted blue) and the other system follows (e.g. figure 2c,
dotted blue). The overall behaviour of the coupled systems is
dominated by the most sensitive system. As their thresholds
approach one another, the systems switch in unison, cooperation
increases, and the switching becomes bistable and hysteretic
(e.g. figure 2c,d, dottedgreen). The cooperation is robust: theanti-
toxin stabilities must differ more than eightfold to eliminate the
hysteresis. However, these results describe the coupling of two
systems differing by only a single kinetic parameter. Coupling,if any, between two completely unrelated toxin–antitoxin
systems requires a more comprehensive analysis.3.2. Design spaces
The model described by equations (2.3)–(2.6) is capable of
exhibiting a rich phenotypic repertoire, and the individual
phenotypes can be effectively enumerated and analysed
within the system design space, as has been shown with other
biological systems [54–56]. In design space, the behaviour of
each phenotype is described by a dominant subsystem with a
single, analytically defined steady state [52]. Note that
equations (2.3) and (2.4) each have one positive term on the
right-hand side, excluding noise, and multiple negative terms,
while equations (2.5) and (2.6) each use multiple terms to
define X and Y. Biologically, each term represents a process.
For a given set of parameter values, one negative term or one
defining term in each equation may be larger than the others,
or dominate. If the smaller terms, or processes, are ignored,
the behaviour of the remaining subsystem can be analysed
using well-known techniques [57]. There are 32 possible cases,
or combinations of dominant terms, and each case represents
a potentially unique phenotype. In the figures that follow,
each case will be depicted as a region in design space. Table 2
lists all of the regions that are visible in this work, along with
a description of their dominant terms and some properties of
their resulting phenotypes.
Table 2. Summary of characteristics for the regions in design space. As described in the text, each of the numbered regions represents a distinct case in which
a different combination of terms creates a dominant subsystem that can be more effectively analysed. Here, the dominant terms, or processes, are described in
each region. Antitoxin loss and toxin loss are found in equations (2.3) and (2.4), respectively. When the first negative term in either equation dominates, the
principal form of loss is dilution, but when the second negative term dominates, the loss is primarily due to active degradation. Toxic inhibition hinges on
equation (2.5), and when the first term dominates, the toxic inhibition of protein production is considered low; when the second term dominates, or the toxin
concentration rises above KT, toxic inhibition is considered high. Transcriptional repression is described by equation (2.6), and when the first term dominates, the
promoter is unbound, but when the third term dominates, the toxin–antitoxin complex acts as a strong autorepressor by cooperatively binding the promoter.
Each region exhibits a distinct phenotypic behaviour, including the toxin concentration, growth rate and system stability, which are shown here. More detailed
descriptions of the relevant regions and their significance can be found in the text.
region
dominant terms system phenotype
antitoxin
loss toxin loss
toxic
inhibition repression
toxin
concentration
growth
rate
system
stability
1 dilution dilution low none low fast stable
3 dilution dilution low cooperative low fast stable
7 dilution dilution high cooperative medium moderate stable
17 degradation dilution low none low fast stable
19 degradation dilution low cooperative low fast stable
21 degradation dilution high none high slow stable
23 degradation dilution high cooperative medium moderate unstable
27 degradation degradation low cooperative medium moderate stable
29 degradation degradation high none high slow stable
31 degradation degradation high cooperative high slow stable
−4
−2−4 0 2 4
−2
0
2
4
3
19
21
29
31
19,21,23
19,23,29
19,23,31
log2 lA/lA
0
lo
g 2
 b
/b
0
Figure 3. System design space for a changing rate constant of antitoxin
degradation lA. Each coloured region represents a different dominant subsys-
tem, or phenotype. The axes represent a fold change in the parameters
relative to the normal operating point (black circle) in Region 3. Holding
the other parameters constant (dashed line) and increasing the rate constant
of antitoxin degradation eightfold tolA=l0A ¼ 8 moves the system to a new
operating point (white circle) in Region 21. See table 2 for additional information
regarding the regions.
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6Figure 3 depicts the design space over a wide range of
parameter values. The normal operating point—defined by
the originally estimated parameters—resides within Region 3,
where dilution dominates in equations (2.3) and (2.4), free
toxin is below its Km in equation (2.5), and transcription is
mostly repressed by the cooperative complex, or the third
term, in equation (2.6). The result is a phenotype with normal,
or relatively fast, growth. Under stressful conditions, increased
proteolytic activity increases the active degradation of the anti-
toxin, which is represented by moving to the right in figure 3.
If the antitoxin half-life is reduced eightfold (lA=l0A ¼ 8), the
system moves from Region 3 to 21, where active degradation
dominates the first equation, dilution still dominates the
second equation, free toxin is above its Km in the third equation,
and transcription is completely derepressed in the fourth
equation. In other words, the toxin concentration rises and
the growth rate falls. Notably, the system passes through a
region of multiple phenotypes, or steady states. Our previous
work showed that the intermediate regions represent a hystere-
tic transition between two stable steady states—high and low
toxin levels—with an intermediate, unstable steady state [30].
Hysteresis, or bistability, is not evident in the toxin profile of
figure 2a, but we also noted in our previous work that design
space can overestimate the size of the hysteretic region, in
which systems that do not exhibit hysteresis can still exhibit a
supralinear, or ultrasensitive, profile. Indeed, figure 2a displays
such ultrasensitivity. Furthermore, figure 3 indicates that the
same behaviour should be expected over a wide range: if b is
increased or decreased by twofold, an increase in lA would
also move the system from Region 3 to Region 21, albeit at
a different value of lA. In fact, the boundaries are linear
functions of the multiplicative parameter values [52], and
therefore mathematically relate the changing threshold to thechange in b. Simple observation indicates that halving b
would halve the change required of lA to reach the threshold.
In the same fashion, design space analysis can be used to
explore the global behaviour of the nonlinear system over
wide ranges of every parameter value—the impact of the
other parameters is shown in the full set of design spaces
depicted in figure 4. In nearly every case, a twofold increase
or decrease in the parameter value does not change the system’s
hysteretic response to increasing lA. As for the threshold of
transition, increasing amax, KP2 or KH moves it closer to the
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7normal operating point, whereas increasing b, mmax, s or KT
moves the threshold farther away. Decreasing any of those par-
ameters has the opposite effect. Changing lT or KP1 has little to
no effect.
Decreasing b—a concomitant decrease in protein syn-
thesis and growth—exhibits similar hysteretic behaviour, as
shown in figure 5a. An eightfold decrease in b moves the
system from Region 3 to Region 29, which is similar to
Region 21 save that active degradation dominates in equation
(2.4). In other words, the toxin concentration is high and the
growth rate is even lower than in Region 21. The transition is
hysteretic, similar to the transition induced by increasing pro-
teolytic activity [30]. Furthermore, figure 4b,d shows that it is
the decrease in maximum growth rate mmax, not the decrease
in maximum protein production amax, that induces the
change in phenotype. As in figure 4, the design spaces of
figure 5 indicate how each parameter affects the threshold
of hysteresis when lowering b. Increasing lA, amax, KP2 or
KH moves the threshold closer to the normal operating
point; increasing mmax, s or KT moves the threshold farther
away. Decreasing those parameters has the opposite effect.
Changing lT or KP1 has little to no effect.3.3. Steady states
In each case, the dominant subsystem can be analytically
solved for a single steady state [52]. Of particular interest
are the steady-state concentrations at the endpoints of the
hysteretic switch, in Regions 3, 21 and 29. The concentrations,
in terms of the independent parameters, are described by
equations (3.1)–(3.6).
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8Equations (3.1) and (3.2) indicate that the steady-state concen-
trations in Region 3 are not dependent on lA. However, as
previously shown, an eightfold increase in lA shifts the
system to Region 21, where equation (3.4) reveals that the
toxin concentration is higher, but again independent of lA.
Together, equations (3.2) and (3.4) define the low and high
toxin levels of a hysteretic switch that is sensitive to increased
proteolytic activity. Similarly, an eightfold decrease in b
shifts the system from Region 3 to Region 29, where the
steady-state solutions are described by equations (3.5) and
(3.6). Interestingly, the equations show that the concentrations
remain dependent on b, so a further decrease in bwill continue
to decrease the toxin and antitoxin, albeit relatively slowly.
Regardless, equations (3.2) and (3.6) define the low and high
toxin concentrations of a hysteretic switch that is sensitive to
the rate of protein production, or growth.3.4. Alternative designs
The characteristics of the hysteretic switch depend on the
parameter values, and the parameter values vary among
toxin–antitoxin systems. The normal operating point is a
representative estimate of measured parameter values in
several well-studied systems [30] and is listed as design S1in table 1. The table also describes pseudo-random alternative
designs, or parameter sets, where each set includes multiple
fold changes to the parameters of the normal operating
point. Although none of the alternative designs represents a
specific toxin–antitoxin system, the variations are typical of
those seen in experimentally characterized systems [30]. For
example, the antitoxin YefM has a measured half-life of
60 min [58], the value at the normal operating point, but
Phd has a half-life of 120 min [59], a value used in alternative
designs S2, S5 and S7. Furthermore, the promoter dis-
sociation constant KP1 of Phd [39,60,61] is at least an order
of magnitude lower than other well-studied systems
[31,41,43,44,62–65], similar to the 10-fold decrease in alterna-
tive design S7. The translational coupling factor in relBE is 10
[66], the normal operating value, but for kis-kid the measured
coupling factor is 2 [67], similar to alternative designs S3
and S4. The toxin and antitoxin typically bind tightly, but
measurements of the dissociation constant KH vary: some
estimates for ccdAB, mazEF and relBE are lower than the
normal operating value of 100 nM [66,68,69], as is the value
in S6, whereas the measured value for yefM-yoeB is 400 nM
[58], the same value used in S4. Thus, the variation among
the alternative designs is typical of the variation among
toxin–antitoxin systems.
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9The panoply of design spaces in figures 4 and 5, together
with equations (3.2), (3.4) and (3.6), describe the influence of
each parameter on the relevant characteristics of the switch:
the low and high toxin concentrations and the threshold
of transition between them. The information can be used to
predict the behaviour of the alternative designs. In fact, the
alternative designs were chosen to exhibit specific variations in
the toxic profiles, as shown in figure 6. Alternative designs S1,
S2 and S3 were chosen to vary the threshold of toxic switching
while maintaining approximately the same low and high toxin
concentrations, which can be seen in figure 6a,c. Alternative
designs S4, S5 and S6 were chosen to change both the toxic
range and the toxic threshold, which can be seen in figure 6b,d.
Designs S2, S5 and S7 were chosen to exhibit identical toxic pro-
files, despite their kinetic differences. Furthermore, figure 6
shows that none of the toxic profiles exhibits bistability, or
more than one steady state along the curve, which is a result of
the relatively low toxic impact n. However, the systems exhibit
switch-like behaviour between two states and behave as
designed, illustrating the potential power of design space to
inform the forward engineering of biological systems.3.5. Heterogeneous cooperativity
Figure 7 describes the effect of coupling the distinctly different
alternative designs. The first system is set to the values for
alternative design S7, and pairedwith each of the other alterna-
tive designs. lA,1 is increased with no corresponding change
in lA,2, which models an increase in proteolytic activity that
only affects the first system. The resulting steady-state toxin
concentrations are shown in figure 7a,b. In every case, thestressed induction of the first system indirectly triggers
the second system. Furthermore, in several cases, the systems
together produce hysteretic behaviour, whereas none was
observed for either system alone (figure 6). Figure 7b indicates
that the cooperative effect depends on the relative toxic
thresholds, but not the relative toxic ranges. The results are
similar when lA,2 is increased alone, or when lA,1 and lA,2
are increased together, as if both systems respond to the
sameprotease (not shown). Figure 7c,d shows similar hysteretic
behaviour when global growth and protein production are
decreased via b. Decreasing mmax alone also exhibits hysteresis
(not shown). We showed in previous work that multiple iden-
tical toxin–antitoxin systems can cooperate to create hysteresis
and increase the size of the bistable region [30]. Here, we show
that extremely different toxin–antitoxin systems also cooperate
when their toxic thresholds are similar, regardless of their toxic
range. Similarly, the cooperation is robust to large changes in
several parameter values, although the effect varies based on
the relative toxic thresholds. As such, the mixing andmatching
of diverse systems via mutation, horizontal gene transfer and
selection can generate a variety of switching profiles, of
which some are optimal for a particular environmental niche.3.6. Stochastic switching
Any member of a population that operates within the bistable
region should tend towards either the low or high toxin
concentration, creating a distinctly bimodal population.
Furthermore, our previous work showed that stochastic fluc-
tuations can spontaneously switch cells from one state to the
other [30]. However, those simulations assumed identical
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10systems with correlated noise. In this work, we used the
coupled model of equations (2.7)–(2.13), and stochastically
simulated the unrelated systems with uncorrelated noise
terms. We poised an entire population at the low toxin con-
centration, which corresponds to normal growth, and then
added noise. Figure 8a,b shows that the toxin concentrations
of the two systems fluctuated independently, generally near
the low toxin concentration at which they were poised. The
systems infrequently and spontaneously switched to fluctu-
ate about the high steady state and appeared to switch
together. As a result, figure 8c shows that individual mem-
bers of the population infrequently and spontaneously
switched to the slow growth, persistent state and, in at least
one case, subsequently recovered. The transitions are infre-
quent, as is to be expected given that persister frequency in a
population can be as low as 1026 [24]. Numerous additional
simulations exhibited the same behaviour, and mirror the sto-
chastic behaviour we thoroughly tested and described in our
previous work [30]. Here, the results confirm that the bistability
introduced by unrelated toxin–antitoxin systems can also give
rise to a dynamically changing subpopulation of persisters.4. Discussion
Previous experimental work has shown that the frequency of
persisters in a population is correlated with the number of
toxin–antitoxin systems in the organism [29]. Our previous
work provided a mechanistic link between the two. Using a
simplifiedmodelwhere every toxin–antitoxin systemwas kine-
tically identical, we showed that the frequency of persisters is
related to the width of the bistable region, which is in turndependent on the number of toxin–antitoxin systems in the
cell [30]. By extending the previous work, we are now able to
show that the same result can be accomplished using a more
realistic model that includes toxin–antitoxin systems with dra-
matically different kinetics. The bistable switch can be driven
by proteolysis of the antitoxin, stochastic fluctuation or a
change in the growth rate. The presence of bistability and the
switching threshold itself are dependent on the other par-
ameters of the system. Even if a single system lacks bistability,
multiple systems can be coordinated by the growth rate to pro-
duce the same effect. Other work has shown a similar link
between growth and bistability, where modulating the growth
rate can create an implicit feedback loop, bistabilityandahetero-
geneous population [70]. In our past work, the toxin–antitoxin
systems were kinetically identical. The results here indicate
that kinetically different systems—even systems that are
dramatically different—can be coupled to produce bistability,
and that the strength of the effect, or the size of the bistable
region, is dependent on the relative switching thresholds of
the individual systems.
Experimental work has shown that sufficient stress can
induce persistence [71–73], which can also be seen in our
model (figure 2). However, our model also shows how, under
relatively normal conditions, stochastic fluctuations can spon-
taneously transition toxin–antitoxin systems to the persistent
state. Even when the stochastic fluctuations in each system are
uncorrelated, the toxin–antitoxin systems in a cell switch
together, coupled by the growth rate. The spontaneous, coordi-
nated switch to persistence describes how toxin–antitoxin
systems can give rise to a bimodal population of normal and
persistent cells. We predict that a persistent subpopulation
would always be present, even under normal conditions, as a
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11bet-hedging strategy to survive a catastrophic event. Indeed,
there is some experimental evidence suggesting that this might
be the case [8]. Interestingly, the switch back to the normal
state is also spontaneous, and therefore the time spent in persist-
ence is variable and unpredictable. It is possible that the
emergence from persistence is just as important, if not more
important, than entering it—persisters that emerge too early,
before an environmental stress abates, will still perish.However,
remaining dormant indefinitely is not a viable strategy either. A
persistent subpopulation that survives catastrophemay employ
a bet-hedging strategy of its own: individual members might
randomly revert to normal and thrive if the stress is gone; if
not, the remaining persistent population carries on.
Persister frequency in a wild-type population of E. coli
is typically between 1026 and 1025 [24], but can vary by
species, strain and environment—the frequency in a biofilm of
P. aeruginosa may be as high as 1022 [74]. Experimental results
show that the frequency can be altered dramatically by varying
the overall number of toxin–antitoxin systems in the cell [29].
Our model confirms those results and suggests that the effectis dependent on the average toxic impact of each system [30].
The average toxic impact of each system, in turn, is a function
of their relative toxic thresholds. In other words, adding
toxin–antitoxin systems with similar switching thresholds
increases the persister frequency more than systems with rela-
tively different thresholds. These results offer an explanation
for the abundance, variation and apparent redundancy of unre-
lated toxin–antitoxin systems: the heterogeneous systems can
be mixed and matched by mutation and horizontal
gene transfer, creating populations with varying persister
frequencies, each fit for a particular environmental niche.
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